Trials / Completed
CompletedNCT06385145
A Bioavailability Study of Two Different PEG-rhGH Preparations.
A Randomized, Open-label, Single Dose, 2-period Crossover Bioavailability Study of Two Different Polyethylene Glycol Recombinant Human Growth Hormone(PEG-rhGH) Preparations in Chinese Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-rhGH with new preparation (T) | A single subcutaneous injection of PEG-rhGH with new preparation |
| DRUG | PEG-rhGH with present preparation (R) | A single subcutaneous injection of PEG-rhGH with present preparation |
Timeline
- Start date
- 2024-05-08
- Primary completion
- 2024-07-05
- Completion
- 2025-03-26
- First posted
- 2024-04-25
- Last updated
- 2025-04-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06385145. Inclusion in this directory is not an endorsement.